Indaptus Therapeutics, Inc. (INDP)
↓ Download CSVKey ratios (FY2025)
-661.5%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$19.83M | -$15.37M | -$16.38M | -$14.91M | -$7.73M | -$3.60M | — |
| Net Income | -$20.85M | -$15.02M | -$15.42M | -$14.32M | -$7.71M | -$3.58M | — |
| EPS (Diluted) | $-21.58 | $-44.96 | $-1.83 | $-1.73 | $-1.89 | — | — |
| Total Assets | $9.31M | $7.34M | $14.92M | $28.06M | $40.58M | $1.78M | — |
| Total Liabilities | — | $3.39M | $2.85M | $3.43M | $4.68M | $2.02M | — |
| Shareholders' Equity | $3.15M | $3.94M | $12.08M | $24.63M | $35.90M | -$237.7K | $3.21M |
| Cash & Equivalents | $8.51M | $5.79M | $13.36M | $9.63M | $39.13M | $1.64M | — |
| Operating Cash Flow | -$14.82M | -$12.32M | -$13.41M | -$13.08M | -$11.29M | -$3.32M | — |
| Capital Expenditures | — | — | — | — | $3.9K | — | — |
| Shares Outstanding | 2.17M | 428.8K | 8.40M | 8.40M | 8.26M | 1.94M | — |